Consideration of SLURP1 as a protective protein has also been reported in clinical cohort studies, where it was observed that cancer patients with high levels of SLURP1 in their plasma had a greater chance of surviving than cancer patients with low levels of SLURP1 [15]. The gene discussed is SLURP1; the disease is cancer.